Merz Announces New Five-year FDA Indication for Cellulite Treatment

Merz has announced that the U.S. Food and Drug Administration (FDA) has cleared Cellfina’s new indication statement that shows the benefits of Cellfina last for five years, an increase from the previous three-year indication. Cellfina demonstrated five-year improvement in the appearance of cellulite on the buttocks and thighs of adult females. The FDA clearance is supported by clinical data demonstrating treatment benefits through five years of observation, making it the longest-lasting cellulite treatment on the market cleared by the FDA.Read more from Merz >>